Larynx

Herbal medicinal product: Eucalypti aetheroleumArray,Array,Array, F: Assessment finalised

Retrieved on: 
Thursday, April 18, 2024

Herbal medicinal product: Eucalypti aetheroleumArray,Array,Array, F: Assessment finalised

Key Points: 


Herbal medicinal product: Eucalypti aetheroleumArray,Array,Array, F: Assessment finalised

ARS Pharmaceuticals Reviews Recent Clinical Updates and Commercial Opportunity at neffy® Investor Day

Retrieved on: 
Thursday, March 7, 2024

The event included presentations by members of the ARS Pharma management team and by two distinguished allergists, Dr. Jonathan Spergel, M.D., Ph.D. and Dr. Thomas B. Casale, M.D.

Key Points: 
  • The event included presentations by members of the ARS Pharma management team and by two distinguished allergists, Dr. Jonathan Spergel, M.D., Ph.D. and Dr. Thomas B. Casale, M.D.
  • Of the patients that do fill their prescription, 80-90% either do not carry or use their treatment as indicated.
  • In late-February, the Company announced positive clinical data from a Phase 2 trial evaluating neffy in adults with chronic spontaneous urticaria.
  • The webcast replay and accompanying slides from today’s investor event may be accessed through the Events & Presentations page in the Investors & Media section of the Company's website.

KalVista Pharmaceuticals Announces Phase 3 KONFIDENT Trial Milestone Achieved

Retrieved on: 
Monday, November 13, 2023

Clinical Trial and Regulatory Updates:

Key Points: 
  • Clinical Trial and Regulatory Updates:
    KalVista has achieved the targeted number of on-treatment attacks required to complete the phase 3 KONFIDENT trial.
  • The Company also expects to file for approval in the European Union and Japan later in 2024.
  • KONFIDENT randomized a total of 136 participants from 66 sites across 20 countries, making it the largest clinical trial ever conducted in HAE based on number of subjects.
  • “We are excited to have reached the number of on-treatment attacks required for completion of KONFIDENT,” said Andrew Crockett, Chief Executive Officer of KalVista.

Why our voices change as we get older

Retrieved on: 
Thursday, June 29, 2023

The 76-year-old singer certainly delivered all his characteristic showmanship.

Key Points: 
  • The 76-year-old singer certainly delivered all his characteristic showmanship.
  • Equally, it’s not all down to the process of ageing.

The sound of your voice

    • The vocal cords are what produce the sound of your voice.
    • When air passes out of the lungs and through the larynx, it causes the vocal cords to vibrate – producing sound.
    • There are also approximately 17 other muscles in the larynx that can alter vocal cord position and tension – thus changing the sound produced.
    • For instance, a woman’s voice may sound different depending on the stage of her menstrual cycle – with the best voice quality being in the ovulatory phase.

Everything ages

    • As we get older, the larynx begins increasing its mineral content, making it stiffer and more like bone than cartilage.
    • The muscles that allow the vocal cords to move also begin wasting (as do our other muscles) as we age.
    • The ligaments and tissues that support the vocal cords also lose elasticity, becoming less flexible.

Lifestyle is a factor

    • Smoking, for example, causes localised inflammation, increased mucous production, but can also dry out the mucosal surfaces.
    • Blood thinners may also damage the vocal cords and can cause polyps to form, making the voice sound raspy or hoarse.
    • One other lifestyle factor can be overuse, which is typically seen in singers and other people who use their voice a lot during work, such as teachers and fitness instructors.

Maintaining our vocal quality

    • While we can’t help some of the age-related changes that happen to our vocal cords, we can maintain some of our vocal quality and ability through continued use.
    • Singing or reading out loud daily can give the vocal cords sufficient exercise to slow their decline.

Head & Neck Cancer Alliance Holds Inaugural Move-a-Thon in April 2023

Retrieved on: 
Tuesday, March 14, 2023

CHARLESTON, S.C., March 14, 2023 /PRNewswire-PRWeb/ -- The Head & Neck Cancer Alliance (HNCA) will hold its inaugural national Head and Neck Cancer (HNCA) Move-A-Thon in April 2023, which is also Head & Neck Cancer Awareness Month. The HNCA Move-A-Thon is a virtual interactive event that invites the public to raise funds and awareness for head and neck cancers by setting a personal "move" goal to make a difference in the lives of cancer patients, survivors, caregivers and families!

Key Points: 
  • CHARLESTON, S.C., March 14, 2023 /PRNewswire-PRWeb/ -- The Head & Neck Cancer Alliance (HNCA) will hold its inaugural national Head and Neck Cancer (HNCA) Move-A-Thon in April 2023, which is also Head & Neck Cancer Awareness Month .
  • The HNCA Move-a-Thon in April 2023 will happen concurrently with HNCA's 25th annual nationwide campaign – "Oral, Head & Neck Cancer Awareness Week" – to be held April 16 - 22, 2023.
  • During "Oral, Head and Neck Cancer Awareness Week," HNCA promotes a high volume of free oral, head and neck cancer screenings all over the world, plus educational talks, and other awareness programs.
  • The Head & Neck Cancer Alliance's mission is to advance prevention, detection, treatment and rehabilitation of oral, head and neck cancer through public awareness, research and advocacy.

Throat & Tonsil Cancer Survivors Actor Rob Paulsen and Green Day's Jason White Urge Public to Attend Free Local Screenings during Oral, Head & Neck Cancer Awareness Week

Retrieved on: 
Thursday, March 9, 2023

CHARLESTON, S.C., March 9, 2023 /PRNewswire-PRWeb/ -- Rob Paulsen, voice-over actor, and Jason White, Green Day guitarist, – both neck cancer survivors – are joining forces with the Head and Neck Cancer Alliance (HNCA) to promote the benefits of screenings and early detection during HNCA's 25th annual nationwide campaign – "Oral, Head & Neck Cancer Awareness Week" – to be held April 16 - 22, 2023.

Key Points: 
  • During "Oral, Head and Neck Cancer Awareness Week," HNCA promotes a high volume of free oral, head and neck cancer screenings all over the world, plus educational talks, and other awareness programs.
  • Head and neck cancer is a group of cancers affecting the oral cavity (mouth), larynx (voice box), pharynx (throat), sinuses, nasal cavity, or salivary glands.
  • More than 65,000 Americans are diagnosed with head and neck cancer every year, with 14,600 lives lost.
  • The Head & Neck Cancer Alliance's mission is to advance prevention, detection, treatment and rehabilitation of oral, head and neck cancer through public awareness, research and advocacy.

Feinstein Institutes report on early mapping of vagus nerve, unveil novel stimulator for bioelectronic medicine research

Retrieved on: 
Friday, February 24, 2023

Bioelectronic medicine scientists published their early mapping in the journal Brain Stimulation , along with a novel vagus nerve stimulator that can activate targeted fibers, opening up new avenues of vagus nerve stimulation (VNS) research.

Key Points: 
  • Bioelectronic medicine scientists published their early mapping in the journal Brain Stimulation , along with a novel vagus nerve stimulator that can activate targeted fibers, opening up new avenues of vagus nerve stimulation (VNS) research.
  • View the full release here: https://www.businesswire.com/news/home/20230224005280/en/
    Stavros Zanos, MD, PhD, is senior author on the research, which published in the journal Brain Stimulation.
  • The Feinstein Institutes for Medical Research is the global scientific home of bioelectronic medicine, which combines molecular medicine, neuroscience and biomedical engineering.
  • By producing bioelectronic medicine knowledge, disease and injury could one day be treated with our own nerves without costly and potentially harmful pharmaceuticals.

Global Head And Neck Cancer Therapeutics Market Report 2022: Increasing Demand For Immunotherapy Treatment Boosts Growth - ResearchAndMarkets.com

Retrieved on: 
Tuesday, January 10, 2023

Immunotherapy is an innovative treatment for cancer, including head and neck, lymphoma, melanoma, and non-small cell lung cancer.

Key Points: 
  • Immunotherapy is an innovative treatment for cancer, including head and neck, lymphoma, melanoma, and non-small cell lung cancer.
  • Based on the Therapy Type, the Head and Neck Cancer Therapeutics Market is segmented into Chemotherapy, Immunotherapy, and Targeted Therapy.
  • Region-wise, the Head and Neck Cancer Therapeutics Market is analyzed across North America, Europe, Asia Pacific, and LAMEA.
  • The North America segment registered the largest revenue share in the head and neck cancer therapeutics market in 2021.

Becker ENT Now Serving the Areas of East Windsor and West Windsor

Retrieved on: 
Tuesday, January 3, 2023

PRINCETON, N.J., Jan. 3, 2023 /PRNewswire-PRWeb/ -- Becker ENT & Allergy offers a full range of services, including medical and surgical treatment of conditions affecting the ears, nose, throat, and related structures of the head and neck. Board-certified physicians are experts in the latest ENT treatments and technologies and are committed to providing each patient with individualized care.

Key Points: 
  • Becker ENT & Allergy is now serving the areas of East Windsor and West Windsor.
  • Becker ENT & Allergy is now serving the areas of East Windsor and West Windsor !
  • For information relating to services offered in Robbinsville, please visit: https://www.beckerentandallergy.com/locations/robbinsville-nj-ent-doctor
    Becker ENT now offers hearing aid evaluation to East Windsor and West Windsor residents.
  • For ENT services in East Windsor and West Windsor, look no further than Becker ENT to provide the best possible care for patients of all ages.

Laryngoscope Global Market Report 2022

Retrieved on: 
Thursday, December 1, 2022

DUBLIN, Dec. 1, 2022 /PRNewswire/ --The "Laryngoscope Global Market Report 2022" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • DUBLIN, Dec. 1, 2022 /PRNewswire/ --The "Laryngoscope Global Market Report 2022" report has been added to ResearchAndMarkets.com's offering.
  • This report provides the strategists, marketers and senior management with the critical information they need to assess the global laryngoscope market.
  • The report gives a guide to the laryngoscope market which will be shaping and changing our lives over the next ten years and beyond, including the markets response to the challenge of the global pandemic.
  • The main types of the laryngoscope market are indirect laryngoscope and direct laryngoscope.